Literature DB >> 9510821

Hydrogels and hydrocolloids: an objective product comparison.

P Sprung1, Z Hou, D A Ladin.   

Abstract

It is difficult for providers to make selections from the vast array of currently available wound care products. There has been a paucity of objective data generated by a non-biased source comparing one product to another. In order for our Wound Care Team to recommend products for system-wide formulary purchase and patient use, we needed to develop a process for product comparison. A strategy for objective evaluation of hydrocolloid and amorphous hydrogel products was created, and these products were assessed clinically by experienced wound care providers. Laboratory testing included measurement of each product's ability to absorb water versus normal saline versus actual patient wound fluid. There were major differences in various products' abilities to absorb the fluids. These objective data from the laboratory, along with the subjective comparison of clinical performance, allowed our Wound Care Team to objectively rank the hydrocolloids and hydrogels and include those preferred products in our Wound Care Product Formulary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510821

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  3 in total

Review 1.  A dressing history.

Authors:  Douglas Queen; Heather Orsted; Hiromi Sanada; Geoff Sussman
Journal:  Int Wound J       Date:  2004-04       Impact factor: 3.315

2.  Recent advances in topical wound care.

Authors:  Sujata Sarabahi
Journal:  Indian J Plast Surg       Date:  2012-05

3.  Comparison of Hydrogel Produced by Radiation as Applied at the Research Center (Yazd Branch) With MaxGel and Routine Dressing for Second-Degree Burn Repair in Yazd Burn Hospital.

Authors:  Mohammad Taghi Noorbala; Mohammad Noorbala; Mohammad Hossein Dashti-Rahmatabadi; Mahdi Noorbala; Roghaye Noorbala; Behare Mozaffary
Journal:  Iran Red Crescent Med J       Date:  2016-06-21       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.